- Patients who underwent video-assisted thoracic surgery (VATS) sleeve lobectomy for centrally located NSCLC had less blood loss and a shorter postoperative stay compared with patients who received thoracotomy, with similar recurrence-free survival (RFS) and OS.
Why this matters
- Although the use of VATS sleeve lobectomy is increasing, studies comparing outcomes with thoracotomy are lacking.
- 148 patients with centrally located NSCLC underwent VATS sleeve lobectomy (n=54) or thoracotomy sleeve lobectomy (n=94).
- Propensity matching of 39 patient pairs.
- Median follow-up, 44.0 months.
- Funding: None disclosed.
- In the total cohort, VATS patients had significantly better RFS (3-year, 64.8% vs 45.7% and 5-year, 59.3% vs 44.7%; P=.025) and OS (3-year, 81.5% vs 64.9% and 5-year, 72.2% vs 61.7%; P=.026) compared with the thoracotomy group.
- After propensity matching, RFS (50.9% vs 48.7%; P=.445) and OS (79.5% vs 66.7%; P=.198) were not significantly different.
- No significant differences between groups in 30-day mortality.
- After propensity matching, VATS patients had significantly less blood loss (228 vs 246 mL; P=.022) and shorter thoracic drainage period (4.6 vs 6.8 days; P<.001 and postoperative hospital stay vs days p=".033)," but a longer operation duration minutes>
- Retrospective study.